INS and metabolic syndrome: Numerous studies have demonstrated that dyslipidemia in serum and metabolic tissues, such as skeletal muscle, adipose tissue, and liver, is a significant factor contributing to impaired insulin sensitivity, ultimately leading to hyperglycemia (Gross et al. 2017; Jiang et al. 2024; Mulvihill et al. 2011; Qi et al. 2025).